Skip to content

Omega-3 Fatty Acids: Dose Matters

Evidence supporting omega-3 fatty acids for cardiovascular health continues to evolve. Recent meta-analyses suggest that clinically meaningful triglyceride reductions often require higher therapeutic doses than typically consumed in over-the-counter supplementation.

Food-first approaches, including fatty fish consumption, remain strongly supported. However, not all omega-3 supplements demonstrate equivalent bioavailability or effect sizes. Researchers emphasize differentiating between preventive intake and therapeutic dosing.

Precision in language and clarifying expected outcomes and realistic magnitude of benefits may help prevent oversimplified supplementation messaging.

References

Bernasconi, Andrea A., et al. “Effect of Omega-3 Dosage on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.” Mayo Clinic Proceedings, vol. 96, no. 2, 2021, pp. 304–313.

Bhatt, Deepak L., et al. “Cardiovascular Risk Reduction with Icosapent Ethyl.” New England Journal of Medicine, vol. 380, no. 1, 2019, pp. 11–22.